With the analysis among 3,621 patents, we discovered top 448 key players by total patent application. Xencor, Inc., Sumitomo Pharmaceuticals Co., Ltd., Corixa Corp. are dominant in this area. They take 5.72% of the total patent filing.
California, United States
Patent: 73
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 68
Washington, United States
Patent: 66
California, United States
Patent: 59
Basel-Stadt, Switzerland
Patent: 52
California, United States
Patent: 49
Northwest Biotherapeutics, Inc.
F. Hoffmann-La Roche Ltd.
Pierre Fabre Médicament SAS
The General Hospital Corp.
Massachusetts, United States
Patent: 42
With the analysis among 221 patents, we discovered top 31 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Primevax Immuno-Oncology, Inc., Systimmune, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Primevax Immuno-Oncology, Inc.
California, United States
Patent: 42
Washington, United States
Patent: 24
Massachusetts, United States
Patent: 11
Myeloid Therapeutics, Inc.
Massachusetts, United States
Patent: 8
California, United States
Patent: 7
Shanghai Shi, China
Patent: 7
North Carolina, United States
Patent: 6
Genève, Switzerland
Patent: 6
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 5
With the analysis among related 1,365 patents applied in the last 5 years. We discover 417 most active companies in this area. The fast-growing Genocea Biosciences, Inc., MacroGenics, Inc., Memorial Sloan-Kettering Cancer Center take 8.06% of patent filing during this period.
Genocea Biosciences, Inc.
Massachusetts, United States
Patent: 40
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 31
Guangdong Sheng, China
Patent: 28
California, United States
Patent: 26
BEIJING DCTY® BIOTECH CO.,LTD
Beijing Shi, China
Patent: 24
Washington, United States
Patent: 24
Hengruiyuanzheng (Shenzhen) Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 24
Basel-Stadt, Switzerland
Patent: 24
Primevax Immuno-Oncology, Inc.
California, United States
Patent: 22
With the analysis among related 1,365 patents in last 5 years, we discover 276 new entrants. Systimmune, Inc., Guangdong TCRCure Biopharma Technology Co., Ltd, Sichuan Baili Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Washington, United States
Patent: 24
Guangdong TCRCure Biopharma Technology Co., Ltd
Guangdong Sheng, China
Patent: 15
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 14
Massachusetts, United States
Patent: 11
California, United States
Patent: 11
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 11
Taipei Medical University
Taiwan Province, China
Patent: 9
With the analysis among 1,314 patents, we discovered top 147 universities and scientific research institutions by total patent application. Baylor College of Medicine, The Johns Hopkins University, The University of North Carolina at Chapel Hill are dominant in this area. They take 15.60% of the total patent filing.
Baylor College of Medicine
Texas, United States
Patent: 53
The Johns Hopkins University
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 30
President & Fellows of Harvard College
Massachusetts, United States
Patent: 27
The Scripps Research Institute
California, United States
Patent: 23
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 16
Georgia, United States
Patent: 15
Kaohsiung Medical University
Universidad Católica De Córdoba